SEC Form 4 · accession 0001225208-19-003856
BOSTON SCIENTIFIC CORP · BSX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David A Pierce
Officer — EVP,Pres MedSurg
Period of report
Feb 26, 2019
Accepted (ET)
Feb 27, 2019 · 4:18 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000885725
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Feb 26, 2019 | S | 4,508 | $39.8317 | D | 38,940 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This transaction was effected pursuant to a pre-established Rule 10b5-1 trading plan.
- F2Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $39.66 to $40.00, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.